Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort BMC Pulmonary Medicine 14 March 2020;20(1)
Date
03/14/2020
DOI
10.1186/s12890-020-1103-4Scopus ID
2-s2.0-85081733548 (requires institutional sign-in at Scopus site)
65 CitationsAuthor List
Todd JL, Vinisko R, Liu Y, Neely ML, Overton R, Flaherty KR, Noth I, Newby LK, Lasky JA, Olman MA, Hesslinger C, Leonard TB, Palmer SM, Belperio JA, Asi W, Baker A, Beegle S, Condos R, Cordova F, Culver DA, Luckhardt T, Dilling D, Glassberg M, Gulati M, Guntupalli K, Gupta N, Hotchkin D, Huie T, Kaner R, Kim H, Kreider M, Lancaster L, Lederer D, Lee D, Liesching T, Lipchik R, Lobo J, Mageto Y, Menon P, Morrison L, Namen A, Oldham J, Raj R, Ramaswamy M, Russell T, Sachs P, Safdar Z, Sigal B, Silhan L, Strek M, Suliman S, Tabak J, Walia R, Whelan TP
Author
Randolph J. Lipchik MD Professor in the Medicine department at Medical College of Wisconsin